Skip to Content

Company news

Recent highlights

Mathai-Mammen
November 4, 2024 Virtual

Truist Tru-Talks with Parabilis Medicines

Parabilis CEO Mathai Mammen joined Kripa Devarakonda at Truist for a discussion about our Helicon discovery platform, our pipeline of investigational medicines, and our ongoing clinical trial of FOG-001. Click to view the recorded webcast. (Registration required; list Kripa Devarakonda as Truist representative.)

Upcoming events